Why are rare and less scarce cancer diseases

Visiting the countryside, David Humphreys, director of Health Policy Information Unit The Economist, a report on the state of the approach to rare cancer types in Latin America, including the situation in Argentina.

The research, called Serious cancer types in Latin America: Challenges and current opportunities on, to understand more Challenges to improve health care and progress in patients with some rare cancer, those with a population of less than six times per 100,000 residents per year, which focus on Argentina, Brazil, Colombia and Mexico.

Among the data collected, the main obstacles to handle and the opportunities to find the findings found are detailed, to capture the attention of the actors involved in this problem.

"Epidemiological data shows that most of these canals in Latin America, in general, are lower than in countries with higher income. When the census and death levels are examined, it is seen that diseases are scarce in Latin American countries than in richest countries. The local surviving levels are similar to those registered in India, China and South Africa, "said Humphreys.

Based on his research The Economist In response to Merck's request from the Information Unit, they expanded a series of suggestions to improve this approach:

Develop and implement plans or strategies at a national level: As with the Europlan implemented by European countries, Latin America could establish a regional project to accommodate rare rape cannons. This would help to improve the development and implementation of strategic plans.

Create comprehensive records nationally and regionally: Records that link data to cancer have an essential cancer to obtain epidemiological data, a plan that can prevent cancer and rarely occur; exercise control functions. The development of a regional record is the natural step to co-ordinate the data collection of unusual cans in Latin America.

Creating collaboration in research at national, regional and international levels: Oncologic research is essential to gain an understanding of rare cancers and improve the management of their diseases. It is recommended that Latin American countries participating in national, regional and international research initiatives on rare cannons and thus contributing to global knowledge by contributing to " benefit from analogous exchange.

Improve cure through centers of excellence: Developing centers of excellence and networks of experts or organizations is essential. Expert network networks have the potential to reduce outcomes and reduce inequality, as they promote more knowledge of rare cans by making it possible; support medical treatment centers. European models and North America can be modified to be implemented in the Latin American division.

David Humphreys said "in Latin America, there were unusual diseases and access to health, historically, real priority issues for legislators and actors involved. However, due to life expectancy and healthcare, in general, improved in the region, with a longer population increased the number of sustained diseases. "The focus is particularly focused, with over one million new cases per year in Latin America and Caribbean.

Although progress has been made in early diagnosis and national banal plans, there is still much to be done, such as patient and patient registration development; opposing inequalities in handling access. In the case of rare cancers, the challenge is even bigger.

Source link

About chile